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Abstract
Background: Although more than 100 Chlamydia pneumoniae hypothetical proteins have been
predicted to be inclusion membrane proteins, only a few have been experimentally demonstrated
to be in the inclusion membrane. Using antibodies raised with fusion proteins, we characterized
four such hypothetical proteins encoded by two gene clusters (Cpn0146-147 and Cpn0284-285) in
the C. pneumoniae genome.
Results: Cpn0146 and 0147 were detected in the inclusion membrane while Cpn0284 and 0285
inside inclusion and mainly associated with reticulate bodies although all four proteins contain an
N-terminal bi-lobed hydrophobic region, a signature motif assigned to inclusion membrane
proteins. These four hypothetical proteins were only detected in cells infected with C. pneumoniae
but not other chlamydial species, with Cpn0147 at 6 hours and Cpn0146, 0284 & 0285 at 24 hours
after infection. Cpn0146 & 147 but not Cpn0284 and 285 co-localized with a host cell endoplasmic
reticulum marker, a property known to be possessed by some chlamydial inclusion membrane
proteins, when expressed in the host cell cytosol via transgenes. However, the endoplasmic
reticulum localization of the C. pneumoniae inclusion membrane proteins did not result in inhibition
of the subsequent C. pneumoniae infection.
Conclusion: The hypothetical proteins Cpn0146 & 0147 were localized in the C. pneumoniae
inclusion membrane while Cpn0284 & 0285 within the inclusion although all four were predicted
to be Inc proteins, suggesting the need to experimentally characterize the predicted Inc proteins.
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The obligate intracellular chlamydial pathogens include
the species Chlamydia trachomatis (C. trachomatis; [1]) and
C. pneumoniae [2] that mainly infect humans and C. muri-
darum (formerly known as C. trachomatis mouse pneumo-
nitis agent, designated as MoPn, ref: [2]), C. caviae [3], C.
psittaci (38), C. abortus [4] and C. felis [5] that are mainly
animal pathogens. The species C. pneumoniae, C. caviae, C.
psittaci, C. abortus &C. felis are also grouped as an inde-
pendent genus termed Chlamydophilae based on their
genetic relatedness [6]. The C. pneumoniae organisms
infect the human respiratory system, not only causing res-
piratory pathologies but also exacerbating pathologies in
other organs such as the vascular wall [7-10]. The C. caviae
GPIC organisms can infect both the ocular and urogenital
tissues in guinea-pig, which has been used as a model sys-
tem for studying the pathogenesis of Chlamydia-induced
diseases [11]. The C. psittaci 6BC organisms cause avian
chlamydiosis that can lead to serious health problems for
humans who are in close contact with the infected birds
[12]. Both the C. abortus &C. felis organisms can affect the
health of various domesticated animal species [4,13,14].
Despite the profound difference in host range, tissue tro-
pism, disease process, all chlamydial species share similar
genome sequences [1-5] and possess a common intracel-
lular growth cycle with distinct biphasic stages [15].
Chlamydial organisms have adapted an obligate intravac-
uolar growth life style with a two-phase cycle [16,17]. The
infection starts with endocytosis of an infectious elemen-
tary body (EB) into a host cell, followed by rapid differen-
tiation of the EB into a non-infectious but metabolically
active reticulate body (RB). After the RB undergoes
numerous rounds of replication, the progeny RBs can dif-
ferentiate back into EBs before exiting to infect the adja-
cent cells. Chlamydial organisms accomplish all their
biosynthesis and particle assembly within the cytoplasmic
vacuole (designated as inclusion). The chlamydial inclu-
sions not only support chlamydial replication but also
protect the replicating organisms from host defense mech-
anisms such as lysosomal fusion [15,18]. At the same
time, Chlamydia must import nutrients and metabolic
intermediates from host cells into the inclusions [19,20].
However, the molecular mechanisms by which Chlamy-
dia organisms interact with host cells are largely
unknown. The fact that Chlamydia-encoded proteins are
found in the inclusion membrane (designated as Inc;
[21]) suggests that the Inc proteins may participate in the
chlamydial interactions with host cells [22,23]. Therefore,
searching for and characterization of novel inclusion
membrane proteins may provide important information
for understanding chlamydial pathogenic mechanisms.
Various approaches have been utilized to identify chlamy-
dial Inc proteins, including direct antibody detection
[21,24-27], accessibility to host cell cytoplasm immune
proteasome processing [28,29], secretion by heterologous
type III secretion systems [30,31] and common structural
feature-based computer predictions [32,33]. Although a
total of 104 hypothetical proteins encoded in C. pneumo-
niae genome were predicted to be Inc proteins by compu-
ter programs [32,33], only a few were proven to be in the
inclusion membrane of the C. pneumoniae-infected cells
by direct antibody labeling [32]. Since not all Inc proteins
can be identified by computer prediction and not all pre-
dicted Inc proteins are localized in the inclusion mem-
brane of chlamydial organism-infected cells [29,32], it is
critical to use experimental approaches to confirm the
localization of the putative Incs and to further character-
ize the Inc proteins. In the current study, we detected the
hypothetical proteins Cpn0146 & 0147 in the C. pneumo-
niae inclusion membrane and Cpn0284 & 0285 within
the inclusion although all four were predicted to be Inc
proteins [32,33]. Furthermore, Cpn0146 & 0147 but not
Cpn0284 & 0285 co-localized with a host cell endoplas-
mic reticulum (ER) marker when expressed via transgenes
although the ER co-localization did not significantly affect
the subsequent C. pneumoniae infection.
Results
1. Localization of Cpn0146 and 0147 in the inclusion 
membrane and Cpn0284 and Cpn0285 within the inclusion 
of C. pneumoniae-infected cells
Using antibodies raised with C. pneumoniae fusion pro-
teins, we detected the hypothetical proteins Cpn0146 and
0147 in the inclusion membrane while Cpn0284 and
0285 within the inclusion of C. pneumoniae-infected cells
(Fig. 1). Both pAb and mAb antibodies against either
Cpn0146 or Cpn0147 consistently detected a dominant
inclusion membrane signal similar to the signal revealed
by the anti-IncA, but not the anti-CPAFcp [34,35], anti-
MOMP [36] or anti-HSP60 antibodies (Fig. 1A). We fur-
ther took advantage of the isotype difference in the light
chains between the anti-Cpn0147 mAb 7H10 (lambda)
and anti-IncA mAb 2B12.1 (kappa) to co-label these two
proteins in the same samples and found that Cpn0147
and IncA partially overlapped with each other under both
conventional fluorescence and confocal microscopes (Fig.
1B). Since IncA, encoded by the C. pneumoniae ORF
cpn0186, is a known inclusion membrane protein [32,37],
the above observations suggest that Cpn0146 and 0147
are also inclusion membrane proteins. Interestingly, the
antibodies raised with Cpn0284 and 0285 fusion proteins
labeled dominant signals within the inclusions (Fig. 1C),
similar but not identical to the signals revealed by the
anti-MOMP or anti-HSP60 antibodies. It is worth noting
that the anti-Cpn0284 and 0285 antibodies only detected
strong signals in small but not large inclusions (Fig. 1C,
panels a-h) while both the anti-MOMP and anti-HSP60
antibodies detected all inclusions regardless of size (Fig.Page 2 of 12
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inclusions are mainly full of RBs while large inclusions
full of EBs under the experimental conditions (72 hours
after C. pneumoniae infection in the presence of cyclohex-
imide), we can speculate that Cpn0284 and 0285 are
likely to be RB-specific proteins.
2. Specificity of the anti-chlamydial fusion protein 
antibodies
Due to the fact that chlamyial antigens can be picked up
by nonspecific antibodies, we further used several
approaches to confirm the antibody binding specificities.
First, a Western blot assay was used to measure the reactiv-
ity between the anti-fusion protein antibodies and the
GST fusion proteins (Fig. 2A). The anti-Cpn0146, 0147,
0284, 0285 & 0186 (IncA) antibodies only recognized the
corresponding fusion proteins without obvious cross-
reaction with each other despite the common GST tag
shared by all fusion proteins. This is because the titers of
antibodies recognizing the chlamydial protein portions
were higher than the titers of those recognizing GST tag
alone in the anti-fusion protein antisera and when the
anti-fusion protein antisera were diluted high enough, the
anti-GST antibodies were no longer detectable. To further
exclude the GST tag effect, we evaluated the reactivity
between the anti-GST fusion protein antibodies and the
RFP (red fluorescence protein)-C. pneumoniae fusion pro-
teins expressed in transfected cells (Fig. 2B). Again, the
antibodies only detected the corresponding RFP fusion
proteins (panels a, f, k & p) without recognizing the unre-
lated proteins (e, i & m for anti-Cpn0146; b, j & n for anti-
Cpn0147; c, g & o for anti-Cpn0284; d, h & I for anti-
Cpn0285). Finally, the recognition of the endogenous
chlamydial proteins by the anti-fusion protein antibodies
was evaluated using a pre-absorption experiment (Fig.
2C). The binding to the endogenous antigens in the C.
pneumoniae-infected cells by the four anti-fusion protein
antibodies was blocked only by the corresponding
homologous (e, j, o & u) but not the unrelated heterolo-
gous GST fusion proteins (i, m & r for anti-Cpn0146; f, n
& s for anti-Cpn0147; g, k & t for anti-Cpn0284; h, I & p
for Cpn0285). Together, the above experiments have
demonstrated that the anti-fusion protein antibodies can
specifically detect the corresponding endogenous anti-
gens in the C. pneumoniae-infected cells.
3. The hypothetical proteins Cpn0146, 0147, 0284 & 0285 
are unique to the C. pneumoniae species
Cpn0146, 0147, 0284 & 0285 are listed as hypothetical
proteins in the C. penumoniae genome sequence website
[38]. Blast search has revealed no significant homologues
of Cpn0146, 0147, 0284 & 0285 in any other chlamydial
species [39]. We assessed whether the polyclonal antisera
raised with the GST-fusion proteins can pick any signals in
cells infected with other chlamydial species (Fig. 3). All
four antisera detected strong signals in cells infected with
three C. pneumoniae isolates AR39, Mul and 2043 (panels
a-l) but not the C. caviae GPIC (m-p), C. psittaci 6BC (q-t),
C. muridarum MoPn (u-x) and C. trachomatis serovar D (y-
bb) and serovar L2 (cc-ff) organisms. Since some of these
antibodies seemed to preferentially recognize RBs, we also
did a similar immunofluorescence assay using cells that
were infected with various chlamydial organisms for only
18 hours when most intravacuolar organisms are at RB
stages. Again, we found that none of these antibodies
detected any significant signals in cells infected with
chlamydial species rather than the C. pneumoniae species.
These observations are consistent with the sequence hom-
ology search result that no significant homologues of
these 4 C. pneumoniae proteins were found in any other
chlamydial species [39]. Previous studies have shown that
although chlamydial inclusion membrane proteins share
very limited primary sequence homology, they contain a
highly conserved bi-lobed hydrophobic domain [32].
Since all 4 proteins were predicted to be Inc proteins
[32,33], we reanalyzed these 4 protein primary sequences
with the Kyte-Doolittle hydropathy plot program [40,41].
Under this program, the hydrophobic transmembrane
regions are identified by peaks with hydropathy scores
greater than 1.8 when using a window size of 19 [41]. We
found that IncA protein displayed two consecutive peaks
with a hydropathy score above 1.8 in its N-terminal
region and so did all four hypothetical proteins (data not
shown) although not all were localized in the inclusion
membrane (see Fig. 1).
4. Time course expression of Cpn0146, 0147, 0284 & 0285
Using the specific antibodies described above, we moni-
tored the expression patterns of both the inclusion mem-
brane proteins (Cpn0146 & 0147) and the proteins
localized inside inclusions (Cpn0284 & 0285) during
chlamydial infection (Fig. 4). Cpn0147 became detecta-
ble as early as 6 hours (panel h, white arrow), IncA 12
hours (q), Cpn0146, 0284 & 0285 all at 24 hours (d, z, hh
respectively) after C. pneumoniae AR39 infection. These
observations suggest that Cpn0147 is an early protein
while Cpn0146, 0284 & 0285 are late proteins. It is worth
noting that the two Inc proteins Cpn0146 and 0147
remained in the inclusion membrane throughout the rest
of infection cycle once they became detectable, suggesting
that the Inc proteins play essential roles in chlamydial
interactions with host cells throughout the infection
cycles. However, the two RB proteins were only domi-
nantly detected in small inclusions that are full of RBs and
were almost absent in large inclusions that are full of EBs.
This distinct distribution pattern was most obvious
between 48 and 96 hours after C. pneumoniae infection
(panels bb, cc, jj & kk). Interestingly, by 120 hours after
infection, Cpn0284 and 0285 proteins reappeared in allPage 3 of 12
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Localization of Cpn0146, 0147, 0284 & 0285 in C. pneumoniae-infected cellsFigure 1
Localization of Cpn0146, 0147, 0284 & 0285 in C. pneumoniae-infected cells. HeLa cells were infected with C. pneu-
moniae AR39 organisms at an MOI of 0.5 in the presence of 2 μg/ml of cycloheximide for 72 hours. The infected cultures 
grown on coverslips were processed for various immunostainings. (A) Cpn0146 was probed with a mouse antiserum (pAb, 
panel a) and monoclonal antibodies (mAb clones 3G2, panel b, 2F9, panel c, 11F9, panel d) while Cpn0147 by pAb (panel g) and 
mAbs 2G4 (panel h), 4B6 (panel i) and 7H10 (panel j), all of which were raised with the correspodning GST fusion proteins and 
visualized with a Cy3-conjugated goat anti-mouse IgG (red). Control mouse antibodies against IncA (2B12.1, IgG1; panel e), 
MOMP (GZD1E8, IgG1, panel f), CPAFcp (EB3.1, IgG1, panel k), and HSP60 (BC7.1, IgG1, panel l) were used to visualize the 
corresponding antigens. A rabbit anti-AR39 antiserum (R12AR39) together with a Cy2-conjugated goat anti-rabbit IgG (green) 
was used to visualize the C. pneumoniae organisms and Hoechst to visualize DNA. (B) The AR39 organism-infected cell samples 
were co-stained with the anti-Cpn0147 mAb 7H10 (IgG1, lambda; panel a; red), the anti-incA mAb 2B12.1 (IgG1, kappa; panel 
b; green) and DNA Hoechst dye (panel c; blue). The triple Images of the immunostainings were obtained using an AX70 fluo-
rescence microscope equipped with a CCD camera. For confocal microscopic observation (panels e to h), the inclusions were 
visualized with the rabbit antiserum R12AR39 in combination with a goat anti-mouse IgG conjugated with Cy5 (blue, panel g). 
The images were acquired sequentially one color at a time and overlayed in tri-color using a confocal microscope (Olympus, 
provided by the UTHSCSA imaging core). Note that the anti-Cpn0146 and 0147 antibodies detected strong inclusion mem-
brane signals similar to and partially overlapped with that obtained with the anti-IncA but not the other reference antibodies. 
(C) The labelings of Cpn0284 and 0285 with the corresponding pAbs were carried out similarly as described in (A). Note that 
the anti-Cpn0284 and 0285 antibodies labeled strong signals inside small but not large inclusions (panels a-d for Cpn0284 and 
e-h for Cpn0285; white arrows pointing to large inclusions) while the anti-MOMP mAb GZD1E8 labeled all inclusions regard-
less of size (panels i and l).
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Evaluation of the anti-Cpn fusion protein antibody binding specificities using three different methodsFig re 2
Evaluation of the anti-Cpn fusion protein antibody binding specificities using three different methods. (A) Vari-
ous GST-Cpn fusion proteins listed on top of the figure were resolved in SDS polyacrylamide gels and the protein bands were 
transferred onto membranes for Western blot detection with antibodies listed at the bottom of the figure. The molecular 
weight (MW) was listed in kDa on the left while the corresponding fusion protein bands detected were indicated on the right 
of the figure. Star * denotes degradation fragments of fusion proteins. Note that the antibodies only detected the correspond-
ing fusion proteins without cross-reacting with unrelated fusion proteins under the current experimental conditions. In sepa-
rate experiments, pre-absorption of the primary antibodies with corresponding but not unrelated fusion proteins blocked the 
antibody binding to fusion protein bands (data not shown). (B) HeLa cells transfected with the recombinant plasmids pDsRed-
C1 monomer/Cpn0146 (panels a-d), /Cpn0147 (e-h), /Cpn0284 (i-l) and /Cpn0285 (m-p) were processed for immunostaining 
with various antibodies listed along the left of the figure (green) plus Hoechst (Blue). The Cpn proteins were expressed as RFP 
fusion proteins (red). Note that the antibodies only labeled the corresponding homologous gene-transfected cells (panels a, f, k 
& p; yellow) without cross-reacting with the unrelated gene-transfected cells. (C) The anti-Cpn0146, 0147, 0284 and 0285 anti-
bodies were preabsorbed with or without the GST fusion proteins listed on top of the figure followed by immunostaining as 
described in Fig. 1A legend. Note that antibody staining was only blocked by pre-absorption with the corresponding homolo-
gous GST fusion proteins.
BMC Microbiology 2007, 7:38 http://www.biomedcentral.com/1471-2180/7/38large inclusions although in a scatter form along the inclu-
sion periphery.
5. Localization of Cpn0146 & 0147 but not Cpn 0284 & 
0285 in the host cell endoplasmic reticulum
It has been previously shown that IncA proteins from
both C. trachomatis and C. caviae species are associated
with host cell endoplasmic reticulum (ER) when
expressed via transgenes [42] and the ER-localized IncA
proteins can further prevent subsequent chlamydial infec-
tion [42]. We compared the cytosolic distribution patterns
(Fig. 5) and the effects of the cytosolic expression on the
subsequent chlamydial infection between the inclusion
membrane proteins Cpn0146 & 0147 and the RB proteins
Cpn0284 and 0285 (Fig. 6). When the Cpn proteins were
expressed as fusion proteins with RFP as an N-terminal
tag, we found that the Inc proteins Cpn0146, 0147 &
0186 (IncA) co-localized with host cell ER (Fig. 5, panels
n, o & p) while the RB proteins Cpn0284 & 0285 failed to
do so (panels q & r). The co-localization was confirmed
with confocal microscopy (panels s-x). When the trans-
fected HeLa cell samples were subsequently infected with
C. pneumoniae AR39 organisms, we found that the trans-
fected cells were similarly susceptible to the chlamydial
infection regardless of whether the cells expressed RFP
alone or RFP-Cpn fusion proteins (Fig. 6). For example,
there was no significant difference in infection rates
between cells expressing RFP alone and cells expressing
RFP-IncA fusion proteins (p > 0.05) although the RFP-
IncA-transfected cells displayed the lowest infection rates
among the 6 transfected and C. pneumoniae-infected cul-
ture samples. As a positive control, when the rates of infec-
tion with C. caviae GPIC organisms were compared
between HeLa cells expressing RFP alone and RFP GPIC-
IncA fusion proteins, we found that the cells expressing
GPIC-IncA were highly resistant to GPIC organism infec-
tion (Fig. 6, last 2 bars; p < 0.01), which suggests that the
RFP fusion system does not interfere with the function of
Inc proteins. It is clear that the cytosolically expressed Inc
proteins from C. pneumoniae species failed to significantly
alter the susceptibility of the transfected cells to the subse-
quent C. pneumoniae infection.
Discussion
In the current study, we have provided the first experimen-
tal evidence demonstrating that the hypothetical proteins
Detection of Cpn0146, 0147, 0284 and 0285 in cells infected with different species of chlamydial organisms and identification of hydropathy regions in these 4 Cpn proteinsFigure 3
Detection of Cpn0146, 0147, 0284 and 0285 in cells infected with different species of chlamydial organisms and 
identification of hydropathy regions in these 4 Cpn proteins. HeLa cells infected with various chlamydial strains/serov-
ars representing different chlamydial species as listed on top of the figure were processed for immunostainings with four 
mouse polyclonal antibodies as listed along the left side of the figure. The mouse antibody bindings were visualized with a Cy3-
conjugated goat anti-mouse IgG (red) while the chlamydial inclusions were visualized by a rabbit anti-CT395 antiserum plus a 
Cy2-conjugated goat anti-rabbit IgG (green) and DNA by Hoechst (blue). Note that the strains Mul and 2043 are recent clinical 
isolates of C. pneumoniae and all four mouse antisera only detected strong signals in cells infected with the organisms of C. 
pneumoniae species but not other chlamydial species.Page 6 of 12
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are associated with RBs inside the inclusions although all
4 proteins were predicted to be in the inclusion mem-
brane based on their N-terminal bi-lobed hydrophobic
motifs [32,33]. Although the antibodies used for localiz-
ing these four proteins were raised with fusion proteins,
we have convincingly demonstrated that the anti-fusion
protein antibodies specifically recognized the correspond-
ing endogenous antigens during C. pneumoniae infection.
It is interesting that Cpn0147 was detected as early as 6
hours while IncA was only detected 12 hours and
Cpn0146, 0284 & 0285 24 hours after infection. These
differential protein expression patterns suggest that
Cpn0147 and IncA are early genes while Cpn0146, 0284
&0285 late genes although further monitoring transcripts
is required for providing evidence to support the conclu-
sion. Although Cpn0146 and 0147 are encoded in the
same gene cluster and oriented in the same direction in
the C. pneumoniae genome, Cpn0147 is expressed much
earlier than Cpn0146, suggesting that the expression of
these two genes are regulated independently. Regardless
of the difference in the timing of expression, both
Cpn0146 and 0147 proteins remained in the inclusion
membrane once detected. However, the RB proteins
Cpn0284 and 0285 fluctuated along the infection cycle
with strong signals in small inclusions and no or very low
signals in large inclusions between 24 and 96 hours and
reappeared in large inclusions by 120 hours after infec-
tion, suggesting that Cpn0284 & 0285 are RB-specific pro-
teins although more biochemical assays are required for
confirming this conclusion.
Since the identification of the first chlamydial inclusion
membrane protein [21], various features have been
assigned to chlamydial inclusion membrane proteins,
including localization in the inclusion membrane, acces-
sibility to host immunoproteasomal processing, secreta-
bility by various heterologous type III secretion systems,
bi-lobed hydrophobic motifs, ER-like distribution and the
ability to render host cell resistance to subsequent
Monitoring the expression of Cpn0146, 0147, 0284 and 0285 proteins during chlamydial infectionsFigure 4
Monitoring the expression of Cpn0146, 0147, 0284 and 0285 proteins during chlamydial infections. HeLa cells 
infected with C. pneumoniae AR39 organisms for various periods of time as indicated on top of the figures were subjected to 
immunostaining with the anti-Cpn0146 (clone 3G2; panels a-f), anti-Cpn0147 (clone 2G4; panels g-n), anti-Cpn0186 (IncA; 
clone 2B12.1; o-v), anti-Cpn0284 (pAb; w-dd) and anti-Cpn0285 (pAb; ee-ll) antibodies as listed along the left side of the figure 
(red). The rabbit antibody R12AR39 was used to visualize the inclusions (green) and Hoechst dye for DNA (blue). The images 
were acquired using the conventional fluorescence microscope. Note that Cpn0147 protein was first detected 6 hours (panel 
h, white arrow), IncA 12 hours (q, white arrow), Cpn0146, 0284 & 0285 24 hours (panels z & hh respectively, white arrows) 
after infection with C. pneumoniae.Page 7 of 12
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cytosol. Here, we systematically analyzed four predicted
Inc proteins encoded by two separate gene clusters in the
C. pneumoniae genome. We found that Cpn0146 & 0147
but not Cpn0284 & 0285 were localized in the inclusion
membrane during C. pneumoniae infection and co-local-
ized with ER when expressed via transgenes, which sug-
gests that the ability of C. pneumoniae proteins to co-
localize with ER is a more precise predictor for inclusion
membrane localization than the bi-lobed hydrophobic
motifs. However, more studies are required for strength-
ening such a correlation.
Despite the tremendous efforts that have been made in
the past decade in identifying and characterizing chlamy-
dial Inc proteins, the precise functions of the Inc proteins
are largely unknown. Among the numerous Inc proteins
identified in C. trachomatis and C. caviae, some Inc pro-
teins (such as IncA) have been shown to participate in ves-
icle fusion [42-44] while others (such as IncG) to directly
interact with host cell molecules [45-47] during chlamy-
dial infection. Delevoye et al [42] has recently correlated
the oligomerization and ER colocalization of the C. tra-
chomati and C. caviae IncA proteins with their abilities to
prevent subsequent organism infection and to disrupt the
organism developmental cycle of existing infection and
further mapped the functional region to the IncA C-termi-
nal fragment that contains putative leucine zipper
domains. Although C. pneumoniae IncA also contains the
C-terminal putative leucine zipper domains [42] and has
the ability to localize to ER (current study, Fig. 5), it failed
to affect the subsequent C. penumoniae organism infection
(Fig. 6), suggesting that ER localization is not sufficient for
inhibiting chlamydial infection. The fact that none of the
C. pneumoniae Inc proteins tested so far affected the subse-
quent C. pneumoniae infection suggests that Inc proteins
from C. pneumoniae may exert their functions in different
modes due to the unique growth properties of C. pneum-
Localization of RFP-Cpn fusion proteins in host cell endoplasmic reticulum (ER)Figure 5
Localization of RFP-Cpn fusion proteins in host cell endoplasmic reticulum (ER). HeLa cells transfected with 
pDsRed plasmids encoding various C. pneumoniae proteins as listed on top of the figure were subjected to immunofluorescence 
staining. The RFP or RFP fusion proteins were in red while host cell endoplasmic reticulum was labeled with a rabbit antibody 
against Calnexin (as an ER marker) in combination with a goat anti-rabbit IgG conjugated with Cy2 (green) and DNA labeled 
with Hoechst dye (blue). The slides were observed under both conventional fluorescence (panels a-r) and confocal (s-x) micro-
scopes. Note that the microscopic observations revealed ER co-localization of Cpn0146 (panels n & t), 0147 (o & u) & 0186 
(IncA; p & v) but not RFP alone (m & s), Cpn0284 (q & w) or 0285 (r & x).Page 8 of 12
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novel approaches for further characterizing the C. pneumo-
niae Inc proteins.
Methods
1. Cell culture and chlamydial infection
HeLa 229 cell (ATCC, Manassas, VA 20108) monolayers
were infected with C. pneumoniae AR39, Mul or 2043
strains (kindly provided by Dr. Harlan Caldwell, RML,
NIAID, NIH, Hamilton, Montana; Both Mul & 2043
strains are recent clinical isolates), C. caviae GPIC, C. psit-
taci 6BC, C. muridarum (also known as MoPn) or C. tra-
chomatis serovar D or L2 organisms at an MOI of 0.5 in
DMEM (Invitrogen, Carlsbad, CA) with 10% fetal calf
serum (FCS; Atlanta Biologicals, Lawrenceville, GA) and
with or without 2 μg/ml of cycloheximide (Sigma, St. Luis,
MO) for 6 to 120 hours (as indicated in individual exper-
iments). The infected cultures grown on coverslips were
processed for various immunoassays.
2. Prokaryotic expression of C. penumoniae proteins and 
antibody production
The open reading frames (ORFs) coding for hypothetical
proteins Cpn0146, 0147, 0284 and 0285 from the C.
pneumoniae genome [38] were cloned in full-length into
pGEX vectors (Amersham Pharmacia Biotech, Inc., Piscat-
away, NJ) using the C. pneumoniae AR39 organism
genomic DNA as template. We used the ORF designations
described for the CWL029 genome sequence when we
started the C. pneumoniae gene cloning/fusion protein
project. In order to maintain consistence, we are still using
the Cpn designations in the current study although the
DNA template is from AR39 strain organisms. Please note
that Cpn0146 is designated as CP0627, Cpn0147 as
CP0626, Cpn0284 as CP0474 and Cpn0285 as CP0473 in
the AR39 genome sequence. The amino acid sequences of
these 4 proteins are identical between CWL029 and AR39.
The C. pneumoniae proteins were expressed as fusion pro-
teins with glutathione-s-transferase (GST) fused to the N-
terminus of the chlamydial proteins as previously
described [26]. Expression of the fusion proteins was
induced with isopropyl-beta-D-thiogalactoside (IPTG;
Invitrogen) and the fusion proteins were extracted by lys-
ing the bacteria via sonication in a Triton-X100 lysis buffer
(1%TritonX-100, 1 mM PMSF, 75 units/ml of Aprotinin,
20 μM Leupeptin and 1.6 μM Pepstatin). After a high-
speed centrifugation to remove debris, the fusion protein-
containing supernatants were purified using glutathione-
conjugated agarose beads (Pharmacia) and the purified
proteins were used to immunize mice for producing both
polyclonal antisera (pAb; ref: [48] and monoclonal anti-
bodies (mAb; ref: [49]. The fusion protein-specific anti-
bodies were then used to localize the endogenous
proteins in C. pneumoniae-infected cells via an indirect
immunofluorescence assay [50,51].
3. Eukaryotic expression of C. pneumoniae proteins
The C. pneumoniae ORFs Cpn0146, 0147, 0284 &0285
were also cloned into the pDsRed Monomer C1 mamma-
lian expression vector (BD Biosciences Clontech, San Jose,
CA) and expressed as fusion proteins with a Red fluores-
cence protein (RFP) fused to the N-terminus. The recom-
binant plasmids were transfected into HeLa cells using the
lipofectamine 2000 transfection reagent following the
protocol recommended by the manufacture (Invitrogen).
The RFP chlamydial fusion proteins were visualized via
either the fusion tag RFP or the mouse anti-chlamydial
protein antibody labeling 24 hours after transfection or as
indcated in individual experiments. To assess the effects of
the RFP-Cpn fusion proteins on the subsequent chlamy-
dial infection, the transfected cells were infected with C.
pneumoniae AR39 organisms. The infected cultures grown
on coverslips were processed for visualization of the trans-
fection and infection via an immunofluorescence assay.
Cells expressing RFP were counted and % of RFP+ cells
Effects of RFP-Cpn fusion protein expression on the subse-qu n  chlamydial i fectionFigure 6
Effects of RFP-Cpn fusion protein expression on the 
subsequent chlamydial infection. HeLa cells transfected 
with pDsRed plasmids coding for various RFP fusion proteins 
as listed along the X-axis were subjected to infection with 
either C. pneumoniae AR39 or C. caviae GPIC organisms. 72 
(for AR39) or 40 hours (for GPIC) after infection, the cul-
tures were subjected to immunostainings for visualizing RFP 
fusion proteins (red), chlamydial organisms (a rabbit anti-
CT395 IgG plus a Cy2-conjugaed goat anti-Rabbit IgG; green) 
and DNA (Hoechst, blue). The slides were viewed under a 
conventional fluorescence microscope. Approximately 100 
red cells from 5 to 10 random views were counted in each 
experiment and the % of cells infected with chlamydial organ-
isms was calculated. The results from three independent 
experiments were expressed as mean values plus/minus 
standard errors. A two-tailed Student t test was used to ana-
lyze the results. Note that expression of RFP-Cpn fusion 
proteins (including CpnIncA) failed to significantly alter the 
susceptibility of the transfected cells to C. pneumoniae AR39 
organism infection while the expression of RFP-GPICIncA 
prevented the subsequent infection with GPIC organisms. "a" 
indicates statistically insignificant difference (P > 0.05) while 
"b" indicates a highly significant difference (P < 0.01).Page 9 of 12
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experiment, ~100 RFP+ cells were counted from 5 to 10
random views and three separate experiments were car-
ried out. The mean values were compared between the
sample expressing RFP alone and samples expressing RFP-
Cpn fusion proteins using a two-tailed Student t test. The
results were expressed as means plus/minus standard
errors. As a positive control, a recombinant pDsRed plas-
mid encoding the RFP-GPICIncA fusion protein was sim-
ilarly transfected into HeLa cells followed by the C. caviae
GPIC organism infection. The rates of GPIC infection in
RFP+ cells were acquired and analyzed as described above.
4. Immunofluorescence assay
HeLa cells grown on coverslips were fixed with 2% para-
formaldehyde (Sigma) dissolved in PBS for 30 min at
room temperature, followed by permeabilization with 1%
saponin (Sigma) for an additional 30 min. After washing
and blocking, the cell samples were subjected to antibody
and chemical staining. Hoechst (blue, Sigma) was used to
visualize nuclear DNA. A rabbit anti-chlamydial organism
antibody (R12AR39, raised with C. pneumoniae AR39
organisms, unpublished data) or anti-CT395 (raised with
the CT395 fusion protein; CT395 is a GrpE-related chap-
eronin with >70% amino acid sequence identity among
all chlamydial species; unpublished data) plus a goat anti-
rabbit IgG secondary antibody conjugated with Cy2
(green; Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA) was used to visualize chlamydial inclusions.
The mouse antibodies including both polyclonal antisera
(pAbs) and monoclonal antibodies (mAbs) raised against
various reference proteins and the C. pneumoniae GST
fusion proteins plus a goat anti-mouse IgG conjugated
with Cy3 (red; Jackson ImmunoResearch) were used to
visualize the corresponding antigens. In some cases, the
primary antibodies were pre-absorbed with either the cor-
responding or heterologous fusion proteins immobilized
onto agarose beads (Pharmacia) prior to staining cell sam-
ples. The pre-absorption approach was carried by incubat-
ing the antibodies with bead-immobilized antigens for 1
h at room temperature (RT) or overnight at 4°C followed
by pelleting the beads. The remaining supernatants were
used for immunostaining. For the transfected cell sam-
ples, the RFP chlamydial fusion proteins were visualized
via the fusion tag RFP (red) and by co-staining with a
mouse antibody plus a Cy2 conjugate (green). For deter-
mining the subcellular location of the RFP fusion pro-
teins, a rabbit anti-Calnexin antibody (Cat# SPA-860,
Stressgen Bioreagents Corp., Ann Arbor, MI) in combina-
tion with a Cy2-conjugated goat anti-Rabbit IgG (green)
was used to label the host cell endoplasmic reticulum.
The cell samples after the appropriate immuno-labeling
were used for image analysis and acquisition with an
Olympus AX-70 fluorescence microscope equipped with
multiple filter sets (Olympus, Melville, NY) as described
previously [52,53]. Briefly, the multi-color-labeled sam-
ples were exposed under a given filter set at a time and the
single color images were acquired using a Hamamatsu
digital camera. The single color images were then super-
imposed with the software SimplePCI to display multi-
colors. An Olympus FluoView™ Laser Confocal Micro-
scope (Olympus) was used to further analyze the co-
stained samples at the UTHSCSA institutional core facil-
ity. All microscopic images were processed using the
Adobe Photoshop program (Adobe Systems, San Jose,
CA).
5. Western blot assay
The Western blot assay was carried out as described else-
where [51,54]. Briefly, the chlamydial GST fusion proteins
were solublized in 2% SDS sample buffer and loaded to
SDS polyacrylamide gel wells. After electrophoresis, the
proteins were transferred to nitrocellulose membranes
and the blots were detected with primary antibodies. The
primary antibody binding was probed with an HRP
(horse radish peroxidase)-conjugated secondary antibody
and visualized with an enhanced chemiluminescence
(ECL) kit (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). In some cases, the primary antibodies were also sub-
jected to pre-absorption as described above prior to react-
ing with the nitrocellulose membrane.
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